1037 ET - Hims & Hers Health logged heavy revenue gains in 3Q in part from its compounded weight-loss drug business, but the company's core telehealth business looked strong too, Piper Sandler analysts Korinne Wolfmeyer and Sarah Morin say in a research note. Management called out strong demand across the Hers platform, which focuses on women's health and personal care, as well as rising demand for personalized offerings and medications that treat multiple conditions at once, the analysts say. Stripping out the weight-loss business, the company's subscriber count in 3Q was still more than 40% higher year-over-year. (dean.seal@wsj.com)
(END) Dow Jones Newswires
November 05, 2024 10:37 ET (15:37 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.